Chemokines And Redox Homeostasis In Aging: A Dynamic Relationship

Aging Pathway
Therapeutic
The intricate relationship between chemokines, which are signaling proteins that guide immune cells, and redox homeostasis, the balance of oxidizing and antioxidant processes in cells, plays a significant role in the aging process and the development of age-related diseases.
Author

Gemini

Published

May 11, 2026

As we age, our bodies undergo numerous changes, and two key players in this process are tiny signaling proteins called chemokines and a fundamental cellular balance known as redox homeostasis. Chemokines act like chemical messengers, directing immune cells to specific locations in the body. While essential for fighting infections and repairing tissues, their activity can become dysregulated with age, leading to a state of chronic, low-grade inflammation often referred to as “inflammaging.” This persistent inflammation is a major contributor to many age-related diseases.

Simultaneously, our cells are constantly managing a delicate balance between producing reactive molecules, known as reactive oxygen species (ROS), and neutralizing them with antioxidants. This balance is called redox homeostasis. With aging, this balance often tips, leading to an increase in ROS production and a decline in our antioxidant defenses, a condition known as oxidative stress. This oxidative stress can damage vital cellular components like DNA, proteins, and fats, contributing to cellular dysfunction and disease.

The connection between these two systems is profound. Chemokines, by driving inflammatory responses, can intensify oxidative stress. In turn, oxidative stress can influence how chemokines are produced and how they signal, creating a harmful cycle that accelerates aging and the progression of age-related conditions. Understanding this dynamic interplay is crucial for developing new strategies to promote healthy aging and prevent the onset of age-related diseases.


Source: link to paper